Candida albicans and candidalysin in inflammatory disorders and cancer.
Jemima HoGiorgio CamilliJames S GriffithsJonathan P RichardsonNessim KichikJulian R NaglikPublished in: Immunology (2020)
As our understanding of mycology progresses, the impact of fungal microbes on human health has become increasingly evident. Candida albicans is a common commensal fungus that gives rise to local and systemic infections, particularly in immunocompromised patients where it can result in mortality. However, C. albicans has also been quietly linked with a variety of inflammatory disorders, to which it has traditionally been considered incidental; recent studies may now provide new aspects of these relationships for further consideration. This review provides a novel perspective on the impact of C. albicans and its peptide toxin, candidalysin, on human health, exploring their contributions to pathology within a variety of diseases.
Keyphrases
- candida albicans
- human health
- risk assessment
- biofilm formation
- climate change
- end stage renal disease
- oxidative stress
- escherichia coli
- ejection fraction
- newly diagnosed
- chronic kidney disease
- type diabetes
- cardiovascular events
- prognostic factors
- coronary artery disease
- cardiovascular disease
- cystic fibrosis
- squamous cell
- cell wall